MiNDERA Corporation

About

MiNDERA Dx conducts research and development on non-invasive molecular testing for skin cancer and other skin diseases.

South San Francisco,California,United States
11 - 50
http://www.minderadx.com

Highlights

Details

Last Funding Type: Debt Financing
Last Funding Money Raised: $3.50M
Industries: Biotechnology,Health Care,Medical
Founded date: Dec 1, 2013
Number Of Employee: 11 - 50
Operating Status: Active

MiNDERA Dx conducts research and development on non-invasive molecular testing for skin cancer and other skin diseases. The company is currently focused on a technology solution to extract skin biomarkers in a non-invasive manner.

It was founded in 2013 and is based in San Francisco, United States.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

6

$20.52M

MiNDERA Corporation has raised a total of $20.52M in funding over 2 rounds. Their latest funding was raised on Jun 3, 2022 from a Debt Financing round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jun 3, 2022	Debt Financing	$3.50M	—	—	—	Detail
May 12, 2021	Series A	$12M	3	Mountain Group Capital Rockmont Investments Scientific Health Development Partners	—	Detail
Nov 16, 2018	Seed	$2.92M	—	—	—	Detail
Dec 1, 2016	Seed	—	3	—	—	Detail
Oct 13, 2015	Seed	$1M	2	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

3

8

MiNDERA Corporation is funded by 8 investors. Mountain Group Capital and Rockmont Investments are the most recent investors.

Investor Name	Lead Investor	Funding Round
Mountain Group Capital	Yes	Series A
Rockmont Investments	Yes	Series A
Scientific Health Development Partners	Yes	Series A
MIT Alumni Angels of Northern California	—	Seed
Primer Capital	—	Seed
Andrew Offer	—	Seed
MedTech Innovator	—	Grant
Philippe Nore	—	Grant